OthersOthers
Submission of 33rd Annual Report for the Financial Year 2025-26 under Regulation 34 of SEBI (LODR), Regulations, 2015
Oxygenta Pharmaceutical Ltd524636 · Filed with the exchange
No comments yet. Be the first.
Read the original filing(PDF)